Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03887104 · ClinicalTrials.gov registry record

Data Collection of OCT and OCTA-based Ocular Measurements

A clinical trial, sponsored by Optovue.

Completed
Registry status
482
Enrollment target

NCT03887104: Completed study, sponsored by Optovue.

NCT03887104 is a clinical trial that has completed, run by Optovue. The registered enrollment target is 482 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03887104 has completed, sponsored by Optovue.

COMPLETED
Registry status
482 participants
Enrollment target

Study Summary

Data Collection of OCT and OCTA-based Ocular Measurements

Primary Outcome

micrometers

Interventions

  • DEVICE SD-OCT

Trial Details

FieldValue
Enrollment Target 482 participants
Start Date 2019-02-08
Est. Completion 2019-08-30
Optovue

12 total trials

What the finished NCT03887104 record still lists

NCT03887104 is an observational study that tracks outcomes without assigning an intervention. The registered 482 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which SD-OCT is the first listed.

NCT03887104 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03887104 about?

NCT03887104 is a clinical study titled "Data Collection of OCT and OCTA-based Ocular Measurements". Data Collection of OCT and OCTA-based Ocular Measurements

What is the current status of trial NCT03887104?

This trial is currently completed. The enrollment target is 482 participants. The study started on 2019-02-08. Estimated completion is 2019-08-30.

What interventions are being tested in trial NCT03887104?

The interventions under investigation include: SD-OCT (DEVICE).

Who is sponsoring clinical trial NCT03887104?

This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04449458 · 482 participants · NA

    The Positively Quit Trial for Smoking Cessation

  • NCT07079631 · 482 participants · Phase 1

    A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

  • NCT02871726 · 483 participants · NA

    Transrectal Ultrasound Robot-Assisted Prostate Biopsy

  • NCT05421741 · 484 participants · Phase 4

    Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03887104, the US trial registry maintained by the National Library of Medicine. NCT03887104 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.